[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334220-105":59,"doc-detail-334220-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","case-report-non-invasive-cyto-salivary-sampling-and-biomarker-detection-via-elisa-versus-histopathology-for-diagnosing-oral-potentially-malignant-disorders-insights-from-a-case-control-study","Case report: Non-invasive cyto-salivary sampling and biomarker detection via ELISA versus histopathology for diagnosing oral potentially malignant disorders - Insights from a case-control study","","Oral potentially malignant disorders such as leukoplakia require early detection, yet definitive diagnosis relies on invasive biopsy. This case report describes a 65-year-old man with a buccal mucosa lesion showing a malignant appearance, evaluated using a novel non-invasive cyto-salivary sampling approach combined with ELISA-based tumor biomarker detection and subsequent histopathological analysis. Rapid ELISA results excluded malignancy and aligned with histopathology, highlighting clinical and histopathological features of proliferative verrucous leukoplakia (PVL). The report supports biomarker monitoring to improve oral medicine decision-making.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/case-report-non-invasive-cyto-salivary-sampling-and-biomarker-detection-via-elisa-versus-histopathology-for-diagnosing-oral-potentially-malignant-disorders-insights-from-a-case-control-study/334220/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/case-report-non-invasive-cyto-salivary-sampling-and-biomarker-detection-via-elisa-versus-histopathology-for-diagnosing-oral-potentially-malignant-disorders-insights-from-a-case-control-study/334220.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is early detection of oral potentially malignant disorders important?","Question",{"text":112,"@type":113},"Diagnosis of oral cancer is often delayed, while oral potentially malignant disorders require timely identification and assessment. Early detection supports earlier examination and improves patient outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the non-invasive cyto-salivary sampling approach work in the case?",{"text":117,"@type":113},"The patient underwent non-invasive cyto-salivary sampling with an ELISA immunoassay to detect tumor biomarkers. Results were then compared with biopsy findings from histopathological analysis.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the ELISA test show compared with histopathology?",{"text":121,"@type":113},"Rapid ELISA results excluded signs of malignancy. The biomarker immunophenotypic profile was consistent with the histopathological examination findings.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334220,1790165153,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","TYPE Case Report  \nPUBLISHED 29 November 2024 DOI 10.3389/fimmu.2024.1477477  \nOPEN ACCESS  \nEDITED BY  \nNoah Isakov,  \nBen-Gurion University of the Negev, Israel  \nREVIEWED BY  \nNicola Tumino,  \nBambino Gesù Children ’s Hospital (IRCCS), Italy  \nFrancesco Fazi,  \nSapienza University of Rome, Italy Rachael Sugars,  \nKarolinska Institutet (KI), Sweden  \n*CORRESPONDENCE  \nEmanuela Marcenaro  \n [emanuela.marcenaro@unige.it](emanuela.marcenaro@unige.it)  \nRECEIVED 07 August 2024  \nACCEPTED 11 November 2024  \nPUBLISHED 29 November 2024  \nCITATION  \nRebaudi F, Rebaudi A, De Rosa A, Rebaudi AL, Pesce S, Greppi M, Roghi M, Boggio M, Candiani S and Marcenaro E (2024) Case report: Non-invasive cyto-salivary sampling and biomarker detection via ELISA versus histopathology for diagnosing oral potentially malignant disorders-Insights from a case-control study.  \nFront. Immunol. 15:1477477 .  \ndoi: 10.3389/fimmu.2024.1477477  \nCOPYRIGHT  \n© 2024 Rebaudi, Rebaudi, De Rosa, Rebaudi, Pesce, Greppi, Roghi, Boggio, Candiani and Marcenaro. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nCase report: Non-invasive cytosalivary sampling and biomarker detection via ELISA versus histopathology for diagnosing oral potentially malignant disorders-Insights from a case-control study  \nFederico Rebaudi 1, Alberto Rebaudi 2, Alfredo De Rosa 3, Alberto Luigi Rebaudi 2, Silvia Pesce 1,4, Marco Greppi 1, Marco Roghi 5, Maurizio Boggio 4, Simona Candiani 4,6 and Emanuela Marcenaro 1,4*  \n1 Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy, 2 Private Practice, Genova, Italy, 3 Multidisciplinary Department of Medical-Surgical and Dental Specialties, University of Campania “Luigi Vanvitelli”, Naples, Italy, 4 IRCCS Ospedale Policlinico San Martino, Genoa, Italy,  \n5 Department of Oral Pathology, Istituto Stomatologico Italiano, Milan, Italy, 6 Department of Earth, Environmental and Life Sciences (DISTAV), University of Genoa, Genoa, Italy  \nOral leukoplakia is classiﬁed among oral potentially malignant disorders (OPMDs) by the World Health Organization (WHO) . The visual oral examination (VOE) is the most used method for identifying lesions in their early stages. Given that the diagnosis of oral cancer is often late, there is an urgent need for early detection and examination of oral lesions. Surgical biopsy represents the gold standard as a diagnostic method, but because it is invasive, it cannot be repeated for periodic checks. We report the case of a lesion on the buccal mucosa of a 65-year-old male patient with a malignant appearance. The patient underwent a novel noninvasive cyto-salivary sampling and ELISA immunoassay for tumor biomarker detection and biopsy with histopathological analysis. The rapid ELISA test results excluded signs of malignancy, providing valuable insights into the lesion’simmunophenotypic proﬁle, which were consistent with the histopathological examination ﬁ n dings. This case report highlights the clinical and histopathological characteristics of a lesion with the aspect of Proliferative Verrucous Leukoplakia (PVL), emphasizing its challenging diagnosis and management. The integration of non-invasive cytobrush sampling with biomarker analysis proved valuable in detecting speciﬁc tumor biomarkers, potentially indicating ongoing tumor transformation. Monitoring these markers  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nover time could enhance early detection and management strategies, thereby improving patient outcomes. This approach underscores the utility of noninvasive techniques in phenoty","cbCaioX89NQ9bboa","https://ap.wps.com/l/cbCaioX89NQ9bboa","pdf",4710586,"English","# Introduction\n## Oral potentially malignant disorders and leukoplakia\n## Diagnostic needs and limitations of biopsy\n## Proliferative verrucous leukoplakia (PVL)","[{\"question\":\"Why is early detection of oral potentially malignant disorders important?\",\"answer\":\"Diagnosis of oral cancer is often delayed, while oral potentially malignant disorders require timely identification and assessment. Early detection supports earlier examination and improves patient outcomes.\"},{\"question\":\"How does the non-invasive cyto-salivary sampling approach work in the case?\",\"answer\":\"The patient underwent non-invasive cyto-salivary sampling with an ELISA immunoassay to detect tumor biomarkers. Results were then compared with biopsy findings from histopathological analysis.\"},{\"question\":\"What did the ELISA test show compared with histopathology?\",\"answer\":\"Rapid ELISA results excluded signs of malignancy. The biomarker immunophenotypic profile was consistent with the histopathological examination findings.\"}]","Case report: Non-invasive cyto-salivary sampling and biomarker detection via ELISA versus histopathology for diagnosing oral potentially malignant disorders - Insights from a case-control study | PDF",1790005815,18]